| Title |
A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial
|
|---|---|
| Published in |
Trials, June 2020
|
| DOI | 10.1186/s13063-020-04436-6 |
| Pubmed ID | |
| Authors |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
An error occurred while generating this chart. Please try again later.
No score history available for this output yet. Please try again later.
X Demographics
The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | 28% |
| Belgium | 1 | 6% |
| Brazil | 1 | 6% |
| Mexico | 1 | 6% |
| Unknown | 10 | 56% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 13 | 72% |
| Scientists | 4 | 22% |
| Practitioners (doctors, other healthcare professionals) | 1 | 6% |
Mendeley demographics
The data shown below were compiled from readership statistics for 556 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 556 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 58 | 10% |
| Student > Master | 57 | 10% |
| Researcher | 56 | 10% |
| Other | 25 | 4% |
| Student > Ph. D. Student | 24 | 4% |
| Other | 96 | 17% |
| Unknown | 240 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 121 | 22% |
| Nursing and Health Professions | 47 | 8% |
| Biochemistry, Genetics and Molecular Biology | 16 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 3% |
| Agricultural and Biological Sciences | 13 | 2% |
| Other | 74 | 13% |
| Unknown | 269 | 48% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 May 2021.
All research outputs
#3,513,568
of 28,931,373 outputs
Outputs from Trials
#1,054
of 6,869 outputs
Outputs of similar age
#81,763
of 440,187 outputs
Outputs of similar age from Trials
#33
of 215 outputs
Altmetric has tracked 28,931,373 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,869 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,187 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 215 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.